Literature DB >> 11030821

Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood.

H Dollfus1, R Häfner, H M Hofmann, R A Russo, L Denda, L D Gonzales, C DeCunto, J Premoli, J Melo-Gomez, J P Jorge, R Vesely, M Stubna, J L Dufier, A M Prieur.   

Abstract

OBJECTIVE: To report on the ocular manifestations of the Chronic Infantile Neurological Cutaneous and Articular/Neonatal Onset Multisystem Inflammatory Disease (CINCA/NOMID) syndrome, a rare, recently identified, pediatric multisystem inflammatory disease with chronic cutaneous, neurological, and articular manifestations.
DESIGN: Descriptive case-report study.
SETTING: International collaborative study based on a questionnaire.
RESULTS: We included 31 patients. The mean age at onset of eye manifestations was 4.5 years. Optic disc changes were the most common feature, occurring in 26 patients (83%), including optic disc edema, pseudopapilledema, and optic atrophy. Anterior segment manifestations varying from mild to severe were seen in 13 patients (42%); chronic anterior uveitis, in 17 patients (55%). Moderate to severe visual acuity loss in at least 1 eye was seen in 8 patients (26%) as a consequence of the disease. Posterior synechia, glaucoma, and white iritis were not observed in any patient.
CONCLUSION: Ocular manifestations with potentially sight-threatening complications occur commonly in the CINCA/NOMID syndrome. The distinctive nature of these complications may assist the ophthalmologist in recognizing this rare disorder and distinguishing it from juvenile rheumatoid arthritis.

Entities:  

Mesh:

Year:  2000        PMID: 11030821     DOI: 10.1001/archopht.118.10.1386

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  36 in total

Review 1.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

Review 2.  Behçet syndrome: is it one condition?

Authors:  H Yazici; S Ugurlu; E Seyahi
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 3.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome.

Authors:  A Adán; M Solé; B Corcostegui; R Navarro; A Burés
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

5.  Post-inflammatory retinal dystrophy in CINCA syndrome.

Authors:  Donato Rigante; Achille Stabile; Angelo Minnella; Laura Avallone; Lucia Ziccardi; Giulia Bersani; Giovanna Stifano; Adele Compagnone; Benedetto Falsini
Journal:  Rheumatol Int       Date:  2009-05-08       Impact factor: 2.631

6.  Cryopyrin-associated periodic syndrome presenting with posterior scleritis.

Authors:  Erica R Alvarez; Brady Corless; Apostolos Kontzias; Colleen M Cebulla
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

7.  A Rare Case of Acute Ocular Hypertensive Episode in a Patient with Chronic Infantile Neurological Cutaneous Articular Syndrome.

Authors:  Karen Kar-Wun Chan; Jonathan Chun-Ho Ho; Irene Tak-Yee Yeung; Simon Tak-Chuen Ko
Journal:  Korean J Ophthalmol       Date:  2016-05-18

8.  Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome.

Authors:  A Adán; M Solé; B Corcostegui; R Navarro; A Burés
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 9.  Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians.

Authors:  Jasmin B Kuemmerle-Deschner; Iris Haug
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

10.  Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap).

Authors:  Leigh D Church; Sinisa Savic; Michael F McDermott
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.